Study of JANX007 in Subjects with Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Summary
- Eligibility
- for males ages 18-100 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janux Therapeutics
- ID
- NCT05519449
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 105 study participants
- Last Updated